• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

来自绿巨螳螂的马斯托帕兰-S通过破坏细菌膜表现出抗菌活性。

Mastoparan-S from Sphodromantis viridis exhibits antimicrobial activity by disrupting bacterial membranes.

作者信息

Park Jonggwan, Lee Seulbi, Kang Da Dam, Oh Jun Hee, Kim Hyeongsun, Park Yoonkyung

机构信息

Department of Bioinformatics, Kongju National University, Kongju, 32588, Republic of Korea.

Department of Biomedical Science, Chosun University, Gwangju, 61452, Republic of Korea.

出版信息

AMB Express. 2025 Jul 3;15(1):99. doi: 10.1186/s13568-025-01908-3.

DOI:10.1186/s13568-025-01908-3
PMID:40608174
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12229353/
Abstract

The increasing prevalence of antimicrobial resistance underscores the urgent need for alternative treatments. Antimicrobial peptides (AMPs) are considered viable substitutes for conventional antibiotics due to their broad-spectrum activity and unique mechanisms of action. AMPs are an integral component of the innate immune system in invertebrates. Mastoparan-S, a 14-amino acid AMP originally identified in the praying mantis Sphodromantis viridis reportedly exhibits antimicrobial activity against gram-positive and gram-negative bacteria, as well as fungi. In this study, the antibacterial activity and mechanism of action of chemically-synthesized mastoparan-S are evaluated against Staphylococcus aureus and Pseudomonas aeruginosa. Mastoparan-S exhibits potent antibacterial activity against S. aureus and P. aeruginosa, without inducing cytotoxicity or hemolytic activity in RAW264.7 or HaCaT cells. Mastoparan-S effectively inhibits biofilm formation by S. aureus and P. aeruginosa. Mechanistically, mastopran-S kills bacteria by disrupting the bacterial membrane. Collectively, these findings suggest that mastoparan-S is a potential therapeutic agent for treating S. aureus and P. aeruginosa infections.

摘要

抗菌耐药性的日益普遍凸显了对替代治疗方法的迫切需求。抗菌肽(AMPs)因其广谱活性和独特的作用机制而被认为是传统抗生素的可行替代品。AMPs是无脊椎动物先天免疫系统的一个组成部分。马蜂毒素-S是一种最初在绿巨螳螂中发现的由14个氨基酸组成的抗菌肽,据报道它对革兰氏阳性菌、革兰氏阴性菌以及真菌都具有抗菌活性。在本研究中,评估了化学合成的马蜂毒素-S对金黄色葡萄球菌和铜绿假单胞菌的抗菌活性及作用机制。马蜂毒素-S对金黄色葡萄球菌和铜绿假单胞菌表现出强大的抗菌活性,且在RAW264.7或HaCaT细胞中不诱导细胞毒性或溶血活性。马蜂毒素-S能有效抑制金黄色葡萄球菌和铜绿假单胞菌的生物膜形成。从机制上讲,马蜂毒素-S通过破坏细菌膜来杀死细菌。总体而言,这些发现表明马蜂毒素-S是治疗金黄色葡萄球菌和铜绿假单胞菌感染的潜在治疗剂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6451/12229353/eb52540397b4/13568_2025_1908_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6451/12229353/96e48f6badff/13568_2025_1908_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6451/12229353/840651ef97ab/13568_2025_1908_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6451/12229353/a8ec5e7329b7/13568_2025_1908_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6451/12229353/cbc859485eb2/13568_2025_1908_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6451/12229353/a6ab2b1cbbad/13568_2025_1908_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6451/12229353/11d2e901644f/13568_2025_1908_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6451/12229353/eb52540397b4/13568_2025_1908_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6451/12229353/96e48f6badff/13568_2025_1908_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6451/12229353/840651ef97ab/13568_2025_1908_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6451/12229353/a8ec5e7329b7/13568_2025_1908_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6451/12229353/cbc859485eb2/13568_2025_1908_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6451/12229353/a6ab2b1cbbad/13568_2025_1908_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6451/12229353/11d2e901644f/13568_2025_1908_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6451/12229353/eb52540397b4/13568_2025_1908_Fig7_HTML.jpg

相似文献

1
Mastoparan-S from Sphodromantis viridis exhibits antimicrobial activity by disrupting bacterial membranes.来自绿巨螳螂的马斯托帕兰-S通过破坏细菌膜表现出抗菌活性。
AMB Express. 2025 Jul 3;15(1):99. doi: 10.1186/s13568-025-01908-3.
2
The antibacterial activity and therapeutic potential of the amphibian-derived peptide TB_KKG6K.源自两栖动物的肽TB_KKG6K的抗菌活性及治疗潜力
mSphere. 2025 Jun 25;10(6):e0101624. doi: 10.1128/msphere.01016-24. Epub 2025 May 19.
3
Copper-coated carbon-infiltrated carbon nanotube surfaces effectively inhibit and biofilm formation.铜包覆的碳渗透碳纳米管表面能有效抑制生物膜形成。
Appl Environ Microbiol. 2025 Jul 8:e0105325. doi: 10.1128/aem.01053-25.
4
The nucleobase analog 4-thiouracil hijacks the pyrimidine salvage pathway to inhibit growth.核碱基类似物4-硫尿嘧啶利用嘧啶补救途径来抑制生长。
Microbiol Spectr. 2025 Jul;13(7):e0064025. doi: 10.1128/spectrum.00640-25. Epub 2025 May 27.
5
VLX600, an anticancer iron chelator, exerts antimicrobial effects on infections.VLX600是一种抗癌铁螯合剂,对感染具有抗菌作用。
Microbiol Spectr. 2025 Jun 20:e0071925. doi: 10.1128/spectrum.00719-25.
6
Designing Novel Antimicrobial Agents from the Synthetic Antimicrobial Peptide (Pep-38) to Combat Antibiotic Resistance.从合成抗菌肽(Pep-38)设计新型抗菌剂以对抗抗生素耐药性。
Pharmaceuticals (Basel). 2025 Jun 10;18(6):862. doi: 10.3390/ph18060862.
7
The antimicrobial peptide Cec4 has therapeutic potential against clinical carbapenem-resistant .抗菌肽Cec4对临床耐碳青霉烯类药物具有治疗潜力。
Microbiol Spectr. 2025 Jul;13(7):e0273824. doi: 10.1128/spectrum.02738-24. Epub 2025 May 16.
8
Respiratory tract antimicrobial peptides more effectively killed multiple methicillin-resistant and nontypeable isolates after disruption from biofilm residence.呼吸道抗菌肽在从生物膜驻留中破坏后,能更有效地杀死多种耐甲氧西林和不可分型的分离株。
Microbiol Spectr. 2025 Jun 18:e0306624. doi: 10.1128/spectrum.03066-24.
9
AI-Driven Antimicrobial Peptide Discovery: Mining and Generation.人工智能驱动的抗菌肽发现:挖掘与生成
Acc Chem Res. 2025 Jun 17;58(12):1831-1846. doi: 10.1021/acs.accounts.0c00594. Epub 2025 Jun 3.
10
Antibacterial activity of (M.Bieb.) plant extract.(M.Bieb.)植物提取物的抗菌活性。
J Complement Integr Med. 2024 Jun 19;21(3):370-374. doi: 10.1515/jcim-2023-0306. eCollection 2024 Sep 1.

本文引用的文献

1
CAM/TMA-DPH as a promising alternative to SYTO9/PI for cell viability assessment in bacterial biofilms.CAM/TMA-DPH作为SYTO9/PI的一种有前景的替代方法,用于评估细菌生物膜中的细胞活力。
Front Cell Infect Microbiol. 2025 Jan 21;14:1508016. doi: 10.3389/fcimb.2024.1508016. eCollection 2024.
2
Advantages and Challenges of Using Antimicrobial Peptides in Synergism with Antibiotics for Treating Multidrug-Resistant Bacteria.抗菌肽与抗生素协同用于治疗多重耐药菌的优势与挑战
ACS Infect Dis. 2025 Feb 14;11(2):323-334. doi: 10.1021/acsinfecdis.4c00702. Epub 2025 Jan 24.
3
The current landscape of the antimicrobial peptide melittin and its therapeutic potential.
抗菌肽蜂毒肽的当前研究现状及其治疗潜力。
Front Immunol. 2024 Jan 22;15:1326033. doi: 10.3389/fimmu.2024.1326033. eCollection 2024.
4
Effect of glucose on growth and co-culture of and in artificial sputum medium.葡萄糖对人工痰液培养基中[具体两种物质未给出]生长及共培养的影响。
Heliyon. 2023 Oct 23;9(11):e21469. doi: 10.1016/j.heliyon.2023.e21469. eCollection 2023 Nov.
5
Antimicrobial peptides for combating drug-resistant bacterial infections.用于对抗耐药细菌感染的抗菌肽。
Drug Resist Updat. 2023 May;68:100954. doi: 10.1016/j.drup.2023.100954. Epub 2023 Mar 1.
6
Antimicrobial Peptides and Cell-Penetrating Peptides: Non-Antibiotic Membrane-Targeting Strategies Against Bacterial Infections.抗菌肽与细胞穿透肽:针对细菌感染的非抗生素膜靶向策略
Infect Drug Resist. 2023 Feb 28;16:1203-1219. doi: 10.2147/IDR.S396566. eCollection 2023.
7
Optimization of the Hemolysis Assay for the Assessment of Cytotoxicity.优化溶血试验评估细胞毒性。
Int J Mol Sci. 2023 Feb 2;24(3):2914. doi: 10.3390/ijms24032914.
8
The antimicrobial peptide LI14 combats multidrug-resistant bacterial infections.抗菌肽 LI14 可对抗多重耐药菌感染。
Commun Biol. 2022 Sep 7;5(1):926. doi: 10.1038/s42003-022-03899-4.
9
Antibiotic resistance: The challenges and some emerging strategies for tackling a global menace.抗生素耐药性:应对这一全球威胁的挑战和一些新兴策略。
J Clin Lab Anal. 2022 Sep;36(9):e24655. doi: 10.1002/jcla.24655. Epub 2022 Aug 10.
10
Molecular Mechanisms of Drug Resistance in .肿瘤多药耐药相关基因的分子机制研究进展
Int J Mol Sci. 2022 Jul 22;23(15):8088. doi: 10.3390/ijms23158088.